1. Home
  2. NLY vs VTRS Comparison

NLY vs VTRS Comparison

Compare NLY & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annaly Capital Management Inc.

NLY

Annaly Capital Management Inc.

HOLD

Current Price

$21.21

Market Cap

15.2B

Sector

Real Estate

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.20

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLY
VTRS
Founded
1996
1961
Country
United States
United States
Employees
212
30000
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
17.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NLY
VTRS
Price
$21.21
$13.20
Analyst Decision
Buy
Buy
Analyst Count
11
4
Target Price
$23.45
$13.50
AVG Volume (30 Days)
7.7M
8.3M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
13.19%
3.65%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$188.83
$4.41
Revenue Next Year
$2.40
$1.96
P/E Ratio
$7.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$6.85
52 Week High
$24.52
$16.47

Technical Indicators

Market Signals
Indicator
NLY
VTRS
Relative Strength Index (RSI) 41.72 40.44
Support Level $20.43 $12.90
Resistance Level $23.27 $13.49
Average True Range (ATR) 0.49 0.35
MACD 0.04 0.02
Stochastic Oscillator 38.02 34.16

Price Performance

Historical Comparison
NLY
VTRS

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are: the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: